Skip to main content
logo
Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
11.50
-0.13 (-1.12%)
At close: Sep 2, 2026, 4:00 PM EDT
11.47
-0.03 (-0.26%)
Pre-market: Sep 3, 2026, 6:08 AM EDT

Vir Biotechnology Revenue

Vir Biotechnology had revenue of $238.95M in the quarter ending June 30, 2026, with 19,582.54% growth. This brings the company's revenue in the last twelve months to $303.23M, up 1,495.93% year-over-year. In the year 2025, Vir Biotechnology had annual revenue of $68.56M, down -7.61%.

Revenue (ttm)
$303.23M
Revenue Growth
+1,495.93%
P/S Ratio
6.42
Revenue / Employee
$826,232
Employees
367
Market Cap
1.95B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202568.56M-5.65M-7.61%
Dec 31, 202474.21M-11.98M-13.90%
Dec 31, 202386.18M-1.53B-94.67%
Dec 31, 20221.62B520.38M47.51%
Dec 31, 20211.10B1.02B1,334.39%
Dec 31, 202076.37M68.28M843.86%
Dec 31, 20198.09M-2.58M-24.16%
Dec 31, 201810.67M7.96M293.94%
Dec 31, 20172.71M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Immunocore Holdings430.78M
Vericel306.30M
Maravai LifeSciences Holdings208.78M
Xencor104.97M
Agios Pharmaceuticals98.34M
Nanobiotix38.27M
Stoke Therapeutics27.59M
Generate Biomedicines26.48M
Revenue Rankings

VIR News

More News